Association of visceral adiposity index (VAI) with prognosis in patients with metabolic syndrome and heart failure with reduced ejection fraction.

ABSTRACT:

Background

Visceral Adiposity Index (VAI) is an effective predictor of metabolic syndrome (MetS) and serves as a marker of visceral adiposity. The association between the VAI index and poor prognosis in patients with MetS and Heart failure with reduced ejection fraction (HFrEF) remains unclear. The aim of this study is to evaluate the relationship between VAI and endpoint events in patients with metabolic syndrome and HFrEF.

Methods

This study was a single-center retrospective cohort study. A total of 809 patients with MetS and HFrEF admitted to Hangzhou Hospital of Zhejiang Medical Group from January 2014 to September 2021 were consecutively included. The VAI index was calculated based on anthropometric measurements and laboratory examination results at admission, and patie

SUBMITTER: Wu M 

PROVIDER: S-EPMC11887152 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature